Christopher D. Ozeroff
2021
In 2021, Christopher D. Ozeroff earned a total compensation of $366K as Secretary, Senior Vice President and General Counsel at ARCA biopharma, a 34% decrease compared to previous year.
Compensation breakdown
| Option Awards | $47,171 |
|---|---|
| Salary | $303,744 |
| Other | $15,114 |
| Total | $366,029 |
Ozeroff received $303.7K in salary, accounting for 83% of the total pay in 2021.
Ozeroff also received $47.2K in option awards and $15.1K in other compensation.
Rankings
In 2021, Christopher D. Ozeroff's compensation ranked 11,306th out of 12,397 executives tracked by ExecPay. In other words, Ozeroff earned more than 8.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,306 out of 12,397 | 9th |
Division Manufacturing | 4,990 out of 5,492 | 9th |
Major group Chemicals And Allied Products | 2,210 out of 2,367 | 7th |
Industry group Drugs | 1,966 out of 2,090 | 6th |
Industry In Vitro and In Vivo Diagnostic Substances | 54 out of 61 | 12th |
Source: SEC filing on November 3, 2022.
Ozeroff's colleagues
We found two more compensation records of executives who worked with Christopher D. Ozeroff at ARCA biopharma in 2021.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019